Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat

Benzer Materyaller

• Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses
  Yazar:: Brinkmann, Christel Rothe, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System
  Yazar:: Rasmussen, Thomas A., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
  Yazar:: Gunst, Jesper D, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
  Yazar:: Bjerg Christensen, Ane, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
  Yazar:: Søgaard, Ole S., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)